Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 245

1.

Antiviral activity of limitin against encephalomyocarditis virus, herpes simplex virus, and mouse hepatitis virus: diverse requirements by limitin and alpha interferon for interferon regulatory factor 1.

Kawamoto S, Oritani K, Asada H, Takahashi I, Ishikawa J, Yoshida H, Yamada M, Ishida N, Ujiie H, Masaie H, Tomiyama Y, Matsuzawa Y.

J Virol. 2003 Sep;77(17):9622-31.

2.
3.

A new interferon, limitin, displays equivalent immunomodulatory and antitumor activities without myelosuppressive properties as compared with interferon-alpha.

Kawamoto S, Oritani K, Asakura E, Ishikawa J, Koyama M, Miyano K, Iwamoto M, Yasuda S, Nakakubo H, Hirayama F, Ishida N, Ujiie H, Masaie H, Tomiyama Y.

Exp Hematol. 2004 Sep;32(9):797-805.

PMID:
15345280
4.

Beta interferon and gamma interferon synergize to block viral DNA and virion synthesis in herpes simplex virus-infected cells.

Pierce AT, DeSalvo J, Foster TP, Kosinski A, Weller SK, Halford WP.

J Gen Virol. 2005 Sep;86(Pt 9):2421-32.

5.
6.

Antiviral activity of salmonid gamma interferon against infectious pancreatic necrosis virus and salmonid alphavirus and its dependency on type I interferon.

Sun B, Skjæveland I, Svingerud T, Zou J, Jørgensen J, Robertsen B.

J Virol. 2011 Sep;85(17):9188-98. doi: 10.1128/JVI.00319-11. Epub 2011 Jun 22.

8.

Inhibition of the alpha/beta interferon response by mouse hepatitis virus at multiple levels.

Roth-Cross JK, Martínez-Sobrido L, Scott EP, García-Sastre A, Weiss SR.

J Virol. 2007 Jul;81(13):7189-99. Epub 2007 Apr 25.

10.

Differential effect of murine alpha/beta interferon transgenes on antagonization of herpes simplex virus type 1 replication.

Härle P, Cull V, Agbaga MP, Silverman R, Williams BR, James C, Carr DJ.

J Virol. 2002 Jul;76(13):6558-67.

11.
12.

Differential effects of a novel IFN-zeta/limitin and IFN-alpha on signals for Daxx induction and Crk phosphorylation that couple with growth control of megakaryocytes.

Ishida N, Oritani K, Shiraga M, Yoshida H, Kawamoto S, Ujiie H, Masaie H, Ichii M, Tomiyama Y, Kanakura Y.

Exp Hematol. 2005 Apr;33(4):495-503.

PMID:
15781341
13.

Murine coronavirus delays expression of a subset of interferon-stimulated genes.

Rose KM, Elliott R, Martínez-Sobrido L, García-Sastre A, Weiss SR.

J Virol. 2010 Jun;84(11):5656-69. doi: 10.1128/JVI.00211-10. Epub 2010 Mar 31.

14.

Involvement of the IRF-1 transcription factor in antiviral responses to interferons.

Kimura T, Nakayama K, Penninger J, Kitagawa M, Harada H, Matsuyama T, Tanaka N, Kamijo R, Vilcek J, Mak TW, et al.

Science. 1994 Jun 24;264(5167):1921-4.

PMID:
8009222
16.

Murine Hepatitis Virus nsp14 Exoribonuclease Activity Is Required for Resistance to Innate Immunity.

Case JB, Li Y, Elliott R, Lu X, Graepel KW, Sexton NR, Smith EC, Weiss SR, Denison MR.

J Virol. 2017 Dec 14;92(1). pii: e01531-17. doi: 10.1128/JVI.01531-17. Print 2018 Jan 1.

17.

Limitin: an interferon-like cytokine without myeloerythroid suppressive properties.

Oritani K, Kincade PW, Tomiyama Y.

J Mol Med (Berl). 2001 May;79(4):168-74. Review. Erratum in: J Mol Med 2001 Aug;79(8):475.

PMID:
11409707
18.
20.

Inhibition of type I interferon-mediated antiviral action in human glioma cells by the IKK inhibitors BMS-345541 and TPCA-1.

Du Z, Whitt MA, Baumann J, Garner JM, Morton CL, Davidoff AM, Pfeffer LM.

J Interferon Cytokine Res. 2012 Aug;32(8):368-77. doi: 10.1089/jir.2012.0002. Epub 2012 Apr 17. Erratum in: J Interferon Cytokine Res. 2016 Aug;36(8):525.

Supplemental Content

Support Center